Novartis AG has secured Medicaid coverage for a pricey new sickle cell disease t...
) has secured Medicaid coverage for a pricey new sickle cell disease therapy in two U.S. states just weeks after winning U.S. approval, following an early campaign to convince local officials of its value, according to a company executive and a Reuters review of public filings.
In November, the U.S. Food and Drug Administration approved Adakveo and Global Blood Therapeutic Inc’s Oxbryta, which carries a list price of $125,000 per year. GBT spokesman Steven Immergut said some health plans, including private insurers as well as government-run Medicaid and Medicare, have started to cover Oxbryta on a case-by-case basis. The company said it has received positive feedback from payers in early discussions.
Oxbryta is a once daily pill that treats the disease’s underlying cause by raising hemoglobin levels and preventing the breakdown of red blood cells into a sickle - or crescent moon - shape. Both Novartis and GBT began meeting with state Medicaid officials ahead of the FDA approvals to discuss the treatment and have advocated for its inclusion on formularies, or official reimbursement lists, both companies told Reuters.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck receives FDA approval for Ebola vaccineThe U.S. Food and Drug Administration said on Thursday it granted approval to dr...
Read more »
Exclusive: Nvidia to win unconditional EU okay for $6.8 billion Mellanox buy - sourcesU.S. chipmaker Nvidia is set to win unconditional EU antitrust approval for its ...
Read more »
Prison surveillance footage from Jeffrey Epstein's first suicide attempt has gone missingAssistant US Attorney Jason Swegold told the New York Daily News that the footage of the cell from July 10 could not be found.
Read more »
Latest draft of U.S. federal privacy bill sidesteps key sticking pointsA key U.S. House committee on Wednesday released a draft of a bipartisan consume...
Read more »
FDA grants accelerated approval for Astellas, Seattle Genetics' bladder cancer drugU.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma ...
Read more »
Bernie Sanders nabs key progressive group endorsementPeople's Action represents more than 1 million members in key early-voting states around the country.
Read more »